Cargando…

Characterization of a novel OTX2‐driven stem cell program in Group 3 and Group 4 medulloblastoma

Medulloblastoma (MB) is the most common malignant primary pediatric brain cancer. Among the most aggressive subtypes, Group 3 and Group 4 originate from stem/progenitor cells, frequently metastasize, and often display the worst prognosis, yet we know the least about the molecular mechanisms driving...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stromecki, Margaret, Tatari, Nazanin, Morrison, Ludivine Coudière, Kaur, Ravinder, Zagozewski, Jamie, Palidwor, Gareth, Ramaswamy, Vijay, Skowron, Patryk, Wölfl, Matthias, Milde, Till, Del Bigio, Marc R., Taylor, Michael D., Werbowetski‐Ogilvie, Tamra E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5891039/ https://www.ncbi.nlm.nih.gov/pubmed/29377567 http://dx.doi.org/10.1002/1878-0261.12177

Ejemplares similares

An OTX2-PAX3 signaling axis regulates Group 3 medulloblastoma cell fate
por: Zagozewski, Jamie, et al.
Publicado: (2020)

OTX2 exhibits cell-context-dependent effects on cellular and molecular properties of human embryonic neural precursors and medulloblastoma cells
por: Kaur, Ravinder, et al.
Publicado: (2015)

MDB-21. THE OTX2-REGULATED ALTERNATIVE SPLICING LANDSCAPE CONTROLS DIFFERENTIATION AND RECONSTITUTES THE DEVELOPMENTAL ORIGINS OF GROUP 3 MEDULLOBLASTOMA
por: Saulnier, Olivier, et al.
Publicado: (2023)

Characterization of novel biomarkers in selecting for subtype specific medulloblastoma phenotypes
por: Liang, Lisa, et al.
Publicado: (2015)

Cross-species analysis of SHH medulloblastoma models reveals significant inhibitory effects of trametinib on tumor progression
por: Borlase, Stephanie, et al.
Publicado: (2023)

Metabolism-based targeting of MYC via MPC-SOD2 axis-mediated oxidation promotes cellular differentiation in group 3 medulloblastoma
por: Martell, Emma, et al.
Publicado: (2023)

Combined MEK and JAK/STAT3 pathway inhibition effectively decreases SHH medulloblastoma tumor progression
por: Zagozewski, Jamie, et al.
Publicado: (2022)

Novel glycolipid agents for killing cisplatin-resistant human epithelial ovarian cancer cells
por: Moraya, Amani I., et al.
Publicado: (2017)

Group-specific cellular metabolism in Medulloblastoma
por: Funke, Viktoria L. E., et al.
Publicado: (2023)

MBRS-19. SYNERGISM OF HDAC AND PARP INHIBITORS IN MYC-DRIVEN GROUP 3 MEDULLOBLASTOMA CELLS
por: Vollmer, Johanna, et al.
Publicado: (2020)

Joint Binding of OTX2 and MYC in Promotor Regions Is Associated with High Gene Expression in Medulloblastoma
por: Bunt, Jens, et al.
Publicado: (2011)

Microarray Discovery of New OGT Substrates: The Medulloblastoma Oncogene OTX2 Is O-GlcNAcylated
por: Ortiz-Meoz, Rodrigo F., et al.
Publicado: (2014)

Otx2 promotes granule cell precursor proliferation and Shh-dependent medulloblastoma maintenance in vivo
por: El Nagar, Salsabiel, et al.
Publicado: (2018)

Genetic alterations of TP53 and OTX2 indicate increased risk of relapse in WNT medulloblastomas
por: Goschzik, Tobias, et al.
Publicado: (2022)

Targeting class I histone deacetylase 2 in MYC amplified group 3 medulloblastoma
por: Ecker, Jonas, et al.
Publicado: (2015)

Pluripotent Transcription Factors Possess Distinct Roles in Normal versus Transformed Human Stem Cells
por: Ji, Junfeng, et al.
Publicado: (2009)

Chromatin Accessibility Mapping Identifies Mediators of Basal Transcription and Retinoid-Induced Repression of OTX2 in Medulloblastoma
por: Wortham, Matthew, et al.
Publicado: (2014)

Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypes
por: Sharma, Tanvi, et al.
Publicado: (2019)

Clinical and mutational profiles of adult medulloblastoma groups
por: Wong, Gabriel Chun-Hei, et al.
Publicado: (2020)

MB3W1 is an orthotopic xenograft model for anaplastic medulloblastoma displaying cancer stem cell- and Group 3-properties
por: Dietl, Sebastian, et al.
Publicado: (2016)

MEDB-61. Genetic alterations ofTP53 andOTX2 indicate increased risk of relapse in WNT medulloblastomas
por: Goschzik, Tobias, et al.
Publicado: (2022)

The long non-coding RNA OTX2-AS1 promotes tumor growth and predicts response to BCL-2 inhibition in medulloblastoma
por: Qin, Nan, et al.
Publicado: (2023)

OTX1 and OTX2 as Possible Molecular Markers of Sinonasal Carcinomas and Olfactory Neuroblastomas
por: Pirrone, Cristina, et al.
Publicado: (2017)

The Current Landscape of Targeted Clinical Trials in Non-WNT/Non-SHH Medulloblastoma
por: Ghasemi, David R., et al.
Publicado: (2022)

Downregulation of miR-204 expression defines a highly aggressive subset of Group 3/Group 4 medulloblastomas
por: Bharambe, Harish Shrikrishna, et al.
Publicado: (2019)

Genetic alterations of TP53 and OTX2 indicate increased risk of relapse in WNT medulloblastomas: “it’s a numbers game”—implications for WNT medulloblastoma dose-reduction clinical trials
por: Gottardo, Nicholas G.
Publicado: (2022)

Circular RNA profiling distinguishes medulloblastoma groups and shows aberrant RMST overexpression in WNT medulloblastoma
por: Rickert, Daniel, et al.
Publicado: (2021)

Notch1 regulates the initiation of metastasis and self-renewal of Group 3 medulloblastoma
por: Kahn, Suzana A., et al.
Publicado: (2018)

Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas
por: Kool, Marcel, et al.
Publicado: (2012)

Medulloblastoma with transitional features between Group 3 and Group 4 is associated with good prognosis
por: Łastowska, Maria, et al.
Publicado: (2018)

MEDB-78. Unified rhombic lip origins of Group 3 and Group 4 medulloblastoma
por: Smith, Kyle, et al.
Publicado: (2022)

Photoreceptor cKO of OTX2 Enhances OTX2 Intercellular Transfer in the Retina and Causes Photophobia
por: Pensieri, Pasquale, et al.
Publicado: (2021)

Cerebrospinal fluid cytokines in metastatic group 3 and 4 medulloblastoma
por: Low, Sharon Y. Y., et al.
Publicado: (2020)

The Site of Origin of Medulloblastoma: Surgical Observations Correlated to Molecular Groups
por: Ciobanu-Caraus, Olga, et al.
Publicado: (2023)

Homeoprotein OTX1 and OTX2 involvement in rat myenteric neuron adaptation after DNBS-induced colitis
por: Bistoletti, Michela, et al.
Publicado: (2020)

Medulloblastoma Down Under 2013: a report from the third annual meeting of the International Medulloblastoma Working Group
por: Gottardo, Nicholas G., et al.
Publicado: (2013)

A functional genomics approach to identify pathways of drug resistance in medulloblastoma
por: Bertrand, Kelsey C., et al.
Publicado: (2018)

Publisher Correction: Notch1 regulates the initiation of metastasis and self-renewal of Group 3 medulloblastoma
por: Kahn, Suzana A., et al.
Publicado: (2018)

MBCL-06. RISK STRATIFICATION IMPROVEMENT OF THE HIT2000 AND I-HIT-MED COHORTS USING MOLECULAR SUBTYPES I-VIII OF GROUP 3/4 MEDULLOBLASTOMAS
por: Mynarek, Martin, et al.
Publicado: (2020)

Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples
por: Northcott, Paul A., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_e8nl77dl1eqjsvi7qgkqja1rkp